(3R)-3-azaniumyl-4-(4-bromophenyl)butanoate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (3R)-3-azaniumyl-4-(4-bromophenyl)butanoate
• 化学式: C10H12BrNO2
• 分子量: 258.11
• InChiKey: DAUFDZAPQZNOGC-SECBINFHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Lipid probes and uses thereof
  申请人：THE SCRIPPS RESEARCH INSTITUTE

  公开号：US10168342B2

  公开（公告）日：2019-01-01

  Disclosed herein are methods, compositions, probes, assays and kits for identifying a lipid binding protein as a drug binding target. Also disclosed herein are methods, compositions, and probes for mapping a ligand binding site on a lipid binding protein, identification of lipid binding proteins, generating drug-lipid binding protein profiles, high throughput drug screening, and identification of drugs as potential lipid binding protein ligands.

  披露了用于识别脂质结合蛋白作为药物结合靶点的方法、组合物、探针、检测和试剂盒。此外，还披露了用于绘制脂质结合蛋白上的配体结合位点、识别脂质结合蛋白、生成药物-脂质结合蛋白轮廓、高通量药物筛选以及识别作为潜在脂质结合蛋白配体的药物的方法、组合物和探针。
• [EN] BIPHENYL DERIVATIVES AS MODULATORS OF THE HISTAMINE-H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO<br/>[FR] DÉRIVÉS DE BIPHÉNYLE COMME MODULATEURS DU RÉCEPTEUR H-3 DE L'HISTAMINE UTILES POUR LE TRAITEMENT DE TROUBLES SE RAPPORTANT À CELUI-CI
  申请人：ARENA PHARM INC

  公开号：WO2009058300A1

  公开（公告）日：2009-05-07

  Biphenyl derivatives of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the H3 histamine receptor. (Ia) Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of histamine H3-associated disorders, such as cognitive disorders, epilepsy, brain trauma, depression, obesity, disorders of sleep and wakefulness, such as narcolepsy, shift-work syndrome, drowsiness as a side effect from a medication, maintenance of vigilance to aid in completion of tasks and the like, cataplexy, hypersomnia, somnolence syndrome, jet lag, sleep apnea and the like, attention deficit hyperactivity disorder (ADHD), schizophrenia, allergies, allergic responses in the upper airway, allergic rhinitis, nasal congestion, dementia, Alzheimer's disease, pain and the like.

  式(Ia)联苯衍生物及其调节H3组胺受体活性的药用组合物。本发明化合物及其药用组合物针对治疗与组胺H3受体相关的一系列疾病的方法，包括认知障碍、癫痫、脑创伤、抑郁症、肥胖症、睡眠与觉醒障碍，如嗜睡症、轮班工作综合征、药物副作用引起的嗜睡、保持警觉以帮助完成任务等、猝倒症、过度嗜睡、嗜睡综合征、时差反应、睡眠呼吸暂停等；注意力缺陷多动障碍(ADHD)、精神分裂症、过敏反应、上呼吸道过敏、过敏性鼻炎、鼻塞、痴呆、阿尔茨海默病、疼痛等。
• REAGENTS AND METHODS FOR REPLICATION, TRANSCRIPTION, AND TRANSLATION IN SEMI-SYNTHETIC ORGANISMS
  申请人：The Scripps Research Institute

  公开号：US20200392550A1

  公开（公告）日：2020-12-17

  Disclosed herein are compositions, methods, cells, engineered microorganisms, and kits for increasing the production of proteins or polypeptides comprising one or more unnatural amino acids. Further provided are compositions, cells, engineered microorganisms, and kits for increasing the retention of unnatural nucleic acids encoding the unnatural amino acids in an engineered cell, or semi-synthetic organism.

  本文揭示了一种用于增加含有一个或多个非天然氨基酸的蛋白质或多肽的生产的组合物、方法、细胞、工程微生物和试剂盒。此外，还提供了一种用于增加编码非天然氨基酸的非天然核酸在工程细胞或半合成生物体中的保留的组合物、细胞、工程微生物和试剂盒。
• TRIAZOLE-CROSSLINKED AND THIOETHER-CROSSLINKED PEPTIDOMIMETIC MACROCYCLES
  申请人：Aileron Therapeutics, Inc.

  公开号：US20130210745A1

  公开（公告）日：2013-08-15

  Provided herein are peptidomimetic macrocycles and methods of using such macrocycles for the treatment of disease.

  本文提供了肽类模拟大环化合物以及利用这些大环化合物治疗疾病的方法。
• [EN] PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF<br/>[FR] MACROCYCLES PEPTIDOMIMÉTIQUES ET UTILISATIONS ASSOCIÉES
  申请人：AILERON THERAPEUTICS INC

  公开号：WO2020023502A1

  公开（公告）日：2020-01-30

  The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

  本公开说明描述了合成肽类模拟大环化合物的方法，并且描述了使用肽类模拟大环化合物治疗疾病的方法。本公开说明还描述了使用肽类模拟大环化合物与至少一种其他药物活性剂联合治疗疾病的方法，例如癌症。